The effect of nonsteroidal anti-inflammatory Drugs ibuprofen, flurbiprofen, and diclofenac on in vitro and in vivo growth of mouse fibrosarcoma

Cancer Investigation

Volumn 20, Issue 4, 2002, Pages 490-498

  Hoferová, Zuzana ^a   Fedorocko, Peter ^b   Hofmanová, Jirina ^a   Hofer, Michal ^a   Znojil, Vladimír ^c   Minksová, Katerina ^a   Soucek, Karel ^a   Egyed, Alena ^d   Kozubík, Alois ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b P J AFÁRIK UNIVERSITY   (Slovakia)

^c MASARYK UNIVERSITY   (Czech Republic)

^d INTERCELL AG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; FLURBIPROFEN; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG STRUCTURE; FIBROSARCOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TUMOR GROWTH; ANIMAL; C3H MOUSE; CELL CULTURE; CELL DIVISION; COMPARATIVE STUDY; DRUG EFFECT; EXPERIMENTAL NEOPLASM; IN VITRO STUDY; PATHOLOGY; SURVIVAL RATE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL CYCLE; CELL DIVISION; DICLOFENAC; FIBROSARCOMA; FLURBIPROFEN; IBUPROFEN; MALE; MICE; MICE, INBRED C3H; NEOPLASMS, EXPERIMENTAL; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 0035983724     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120002149     Document Type: Article

References (48)

1. Prostaglandin production is a marker of high metastatic potential for neoplastic cells
2. Increased synthesis of prostacyclin and thromboxane in human ovarian malignancy
3. Prostaglandin and thromboxane synthesis by human intracranial tumors
4. In vivo effects of indomethacine on the growth of murine mammary tumors
5. Commentary. Prostacyclin and thromboxanes: Implications for their role in tumor cell metastasis
6. Prostaglandine, tromboxane, and leukotriene biosynthesis: Target for antitumor and antimetastatic agents
7. The role of eicosanoids in tumor metastasis
8. Prostaglandins, their inhibitors and cancer
9. Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment
10. Effect of indomethacin on intestinal tumor induced in rats by the acetate derivate of dimethylnitrosamine
11. Opposing effects of indomethacin and nordihydroguaiaretic acid on macrophage function and tumor growth
12. The use of indomethacin, sulindac, and tamoxifen for the treatment of desmoid tumors associated with familial polyposis
13. A hyphotesis: Non-steroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer
14. Mechanism of inhibition of tumor growth by aspirin and indomethacin
15. Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin
16. Increase in radioresponse of murine tumors by treatment with indomethacin
17. Dependence of indomethacin-induced potentiation of murine tumor radioresponse on tumor host immuno-competence
18. Improvement in therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus misonidazole
19. Piroxicam, indomethacin and aspirin action on a murine fibrosarcoma. Effects on tumour-associated and peritoneal macrophages
20. Improvement in the therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus fludarabine
21. Prostaglandin production by mouse fibrosarcoma cells in culture: Inhibition by indomethacin and aspirin
22. Successful treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin-producing fibrosarcoma
23. Hydrocortisone inhibits prostaglandin production by mouse fibrosarcoma cells
24. The role of cyclooxygenases in inflammation, cancer, and development
25. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs
26. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs
27. COX2 activity can reduce the level of toxicity for a given NSAID but may not be sufficient to overcome toxicities resulting from other mechanisms
28. Risk for serious gastrointestinal complications related to use of NSAID: A meta-analysis
29. Comparative toxicity of non-steroidal anti-inflammatory agents
30. Prostaglandin endoperoxide synthetase isoenzymes: The clinical relevance of selective inhibition
31. Evidence that the local effect of ultraviolet radiation on the growth of murine melanomas is immunologically mediated
32. Microflurometric analysis of nuclear dna in cells from tumors and cell suspensions
33. Reductive effect of aspirin treatment on primary tumor growth and metastasis of implanted fibrosarcoma in rats
34. Failure of short-term treatment with flurbiprofen to enhance the therapeutic effect of cyclophosphamide against rodent sarcomas and leukemia
35. Modulation of haemopoietic radiation response of mice by diclofenac in fractionated treatment
36. Radioprotective properties of flurbiprofen
37. Induction of suppression by a murine nonspecific suppressor-inducer cell line (M1-A5). II. The role of prostaglandins
38. Enhancement of haemopoietic recovery by indomethacin after sublethal whole-body gamma irradiation
39. Effects of indomethacin, diclofenac sodium and sodium salicylate on peripheral blood cell counts in sublethally gamma-irradiated mice
40. Radioprotection of haematopoietic tissues in mice by indomethacin
41. The stimulatory effect of single-dose pre-irradiation administration of indomethacin and diclofenac on haemopoietic recovery in the spleen of gamma-irradiated mice
42. Effects of drugs inhibiting prostaglandin or leukotriene biosynthesis on postirradiation hematopoiesis in mouse
43. Radioprotective effects of flurbiprofen and its nitroderivative
44. Effects of eicosanoid synthesis inhibitors on the in vitro growth and prostaglandin E and leukotriene B secretion of a human breast cancer cell line
45. Indomethacin stimulation of macrophage cytostasis against MOPC-315 tumor cells is enhanced by endogenous metabolites of lipoxygenase and counteracted by prostaglandin E2
46. 5-Lipoxygenase inhibitors potentiate effects of TGF-β1 on the differentiation of human leukemia HL-60 cells
47. Cyclooxygenase-2: Regulation and relevance in inflammation
48. A better understanding of anti-inflammatory drugs based on isoforms of cyclooxygenase (COX-I and COX-2)